Meridian Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,028
Closed -$649K 398
2021
Q2
$649K Sell
1,028
-728
-41% -$402K 0.08% 192
2021
Q1
$859K Buy
1,756
+1,063
+153% +$533K 0.13% 152
2020
Q4
$346K Buy
693
+18
+3% +$8.05K 0.05% 243
2020
Q3
$265K Hold
675
0.07% 202
2020
Q2
$222K Buy
+675
New +$195K 0.07% 198
2019
Q3
Sell
-630
Closed -$1.74K 319
2019
Q2
$1.74K Buy
+630
New +$155K 0.07% 219
2018
Q4
Sell
-810
Closed -$202K 170
2018
Q3
$202K Buy
+810
New +$197K 0.09% 162

Other funds holding IDXX

Meridian Wealth Management's IDXX Position: Q3 2021 in Review

Meridian Wealth Management sold out of Idexx Laboratories (IDXX) in Q3 2021, closing a stake of 1,028 shares — an estimated $649K sold.

Meridian Wealth Management first reported a position in IDXX in Q3 2018 and held it in 7 quarters. The position peaked at $859K in Q1 2021. 1,058 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

  • Meridian Wealth Management reported no remaining Idexx Laboratories position as of Q3 2021 after selling out during the quarter.
  • Meridian Wealth Management sold 1,028 Idexx Laboratories shares in Q3 2021, an estimated $649K.
  • Meridian Wealth Management first reported a position in Idexx Laboratories in Q3 2018 and held it in 7 quarters.
  • Meridian Wealth Management's Idexx Laboratories position peaked at $859K in Q1 2021.
  • 1,058 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on Meridian Wealth Management's 13F filing for Q3 2021, filed 15 Oct 2021.